<?xml version="1.0" encoding="UTF-8"?>
<ref id="B95-pharmaceuticals-12-00157">
 <label>95.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pascoalino</surname>
    <given-names>B.S.</given-names>
   </name>
   <name>
    <surname>Courtemanche</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Cordeiro</surname>
    <given-names>M.T.</given-names>
   </name>
   <name>
    <surname>Gil</surname>
    <given-names>L.H.</given-names>
   </name>
   <name>
    <surname>Freitas-Junior</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>Zika antiviral chemotherapy: Identification of drugs and promising starting points for drug discovery from an FDA-approved library</article-title>
  <source>F1000Research</source>
  <year>2016</year>
  <volume>5</volume>
  <elocation-id>2523</elocation-id>
  <pub-id pub-id-type="doi">10.12688/f1000research.9648.1</pub-id>
  <pub-id pub-id-type="pmid">27909576</pub-id>
 </element-citation>
</ref>
